Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

BioNTech SE ADR buy skatcup

Start price
€77.54
05.11.20 / 50%
Target price
-
05.11.21
Performance (%)
20.98%
End price
€93.81
27.11.20
Summary
This prediction ended on 27.11.20 with a price of €93.81. The prediction had a final performance of 20.98%. skatcup has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
BioNTech SE ADR 7.896% 7.896% 243.124% -
iShares Core DAX® -0.922% -1.993% 13.399% 16.075%
iShares Nasdaq 100 0.371% -0.868% 41.541% 46.938%
iShares Nikkei 225® 2.224% -5.187% 20.497% 4.643%
iShares S&P 500 -0.026% -0.918% 30.410% 42.418%

According to skatcup what are the pros and cons of BioNTech SE ADR for the foreseeable future?

Pros
Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet
Strong uniques
Growths much faster than the competition
Stable Large shareholder and/or long term investor
Medium risks for its business
Market Leader or Top 3
Very Future proof/growth oriented business model
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Very capable Management
Very good company culture
Innovative
Small cyclical dependencies
Well known brand
Could be worthwhile Investment >10% per year
positive Cash Flow expected
Normal challenges to pay loans and raise capital
Cons

Comments by skatcup for this prediction

In the thread Biontech SE diskutieren

Buy BioNTech SE ADR

In the thread Trading Biontech SE
Prediction Buy
Perf. (%) 20.98%
Target price
Change
Ends at 05.11.21

Buy beendet

Stopped prediction by skatcup for BioNTech SE ADR

buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€131.45
23.01.23
€100.00
23.01.24
-30.00%
24.01.24

Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€134.45
25.01.22
€200.00
25.01.23
16.36%
05.02.22

Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet
buy
BioNTech SE ADR

Start price
Target price
Perf. (%)
€83.96
09.01.21
€300.00
09.01.22
124.99%
10.01.22

Rising EBIT margin expected
Good rating
High Investments for future growth
Valuable balance sheet